. Author manuscript; available in PMC: 2017 Jul 18.

Published in final edited form as: JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):18–26. doi: 10.1001/jamaoto.2014.2669

Table 2.

Summary of Change in Tinnitus Bother and Cognitive Functioning by Treatment Group

Assessments	Median (95% CI)		P Value	Difference, Final-Baseline, Median (95% CI)
Assessments	Baseline Visit	Final Visit	P Value	Difference, Final-Baseline, Median (95% CI)
Placebo and cognitive training (n = 14)
TFI score	44 (14 to 65)	41 (13 to 61)	.35	−1.0 (−11.7 to 4.9)
CFQ score	43 (19 to 60)	43 (13 to 52)	.16	−2.0 (−5.1 to 2.0)
SCWT T-score	58 (43 to 64)	60 (45 to 70)	.09	2.0 (−0.3 to 6.0)
PASAT, No. correct	156 (68 to 194)	174 (103 to 225)	.005	23.0 (3.4 to 31.9)
D-cycloserine and cognitive training (n = 16)
TFI score	47 (10 to 76)	38 (8 to 70)	.04	−5.8 (−9.4 to −1.1)
CFQ score	41 (18 to 51)	34 (18 to 47)	.005	−4.5 (−11.5 to −1.0)
SCWT T-score	54 (40 to 71)	60 (30 to 73)	.12	4.0 (−1.6 to 8.0)
PASAT, No. correct	128 (65 to 229)	157 (83 to 233)	.001	20.0 (12.4 to 37.0)

Abbreviations: CFQ, Cognitive Failures Questionnaire; PASAT, Paced Auditory Serial Addition Test; SCWT, Stroop Color Word Test; TFI, Tinnitus Functional Index.